Your browser doesn't support javascript.
loading
Successful mRNA COVID-19 Vaccination and Colonoscopy After Oral Desensitization in a Patient With Polyethylene Glycol Allergy.
Cha, Boram; Kwon, Kye Sook; Lee, Hong Lyeol; Kim, Cheol-Woo.
Afiliación
  • Cha B; Department of Internal Medicine, Inha University School of Medicine, Incheon, Korea.
  • Kwon KS; Department of Internal Medicine, Inha University School of Medicine, Incheon, Korea.
  • Lee HL; Department of Internal Medicine, Inha University School of Medicine, Incheon, Korea.
  • Kim CW; Department of Internal Medicine, Inha University School of Medicine, Incheon, Korea. cwkim1805@inha.ac.kr.
J Korean Med Sci ; 37(32): e251, 2022 Aug 15.
Article en En | MEDLINE | ID: mdl-35971765
Anaphylaxis to polyethylene glycol (PEG) is rare and mainly occurs with the use of laxatives containing PEG. Recently, an increasing number of PEG allergies have been reported, particularly those related to coronavirus disease 2019 (COVID-19) vaccines. mRNA COVID-19 vaccines, such as the BNT162b2 (Pfizer-BioNTech) and mRNA-1273 (Moderna) vaccines, contain PEG2000 as an excipient and are contraindicated when allergy to a vaccine component exist. We report a 55-year-old woman's history as a case of successful mRNA COVID-19 vaccination and colonoscopy after oral desensitization to PEG in a patient with PEG allergy who required both COVID-19 vaccination and colon evaluation. Allergy to PEG was diagnosed based on clinical history, skin test results, and basophil histamine release testing. Oral desensitization effectively suppressed histamine release from basophils in response to PEG stimulation, suggesting that oral desensitization using PEG-based laxatives may be an effective treatment option for patients with allergy to the substance.
Asunto(s)
Palabras clave

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Vacunas contra la COVID-19 / COVID-19 / Anafilaxia Límite: Female / Humans / Middle aged Idioma: En Revista: J Korean Med Sci Asunto de la revista: MEDICINA Año: 2022 Tipo del documento: Article Pais de publicación: Corea del Sur

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Vacunas contra la COVID-19 / COVID-19 / Anafilaxia Límite: Female / Humans / Middle aged Idioma: En Revista: J Korean Med Sci Asunto de la revista: MEDICINA Año: 2022 Tipo del documento: Article Pais de publicación: Corea del Sur